Form 4: Kindly MD Insider Boosts Stake with Equity Grants

Timothy Pickett, Chief Medical Officer and Director of Kindly MD, Inc., acquired 191,271 shares of common stock through restricted stock units and awards.

Summary

• Timothy Pickett, Chief Medical Officer and Director of Kindly MD, Inc. (NAKA), acquired a total of 191,271 shares of common stock.
• The transactions occurred on September 22, 2025.
• 37,593 shares were Restricted Stock Units (RSUs) with a four-year vesting schedule, including a 12-month cliff period starting August 15, 2025.
• 153,943 shares (comprising 26,129, 10,146, and 18,378 shares) were Restricted Stock Awards that were fully vested as of September 22, 2025.
• All shares were acquired at a price of $0, indicating they are equity compensation grants.
• Following these transactions, Timothy Pickett beneficially owns 191,271 shares directly.
• A Power of Attorney was executed on September 24, 2025, by Timothy Pickett, authorizing specific individuals to execute SEC filings (Schedules 13D/G and Forms 3, 4, 5) on his behalf.

Sentiment

Score: 7

Explanation: The filing reports standard equity compensation for a key executive, which is generally viewed as a positive for aligning management and shareholder interests, though it does not represent a direct cash investment by the insider.

Positives

• Increased insider ownership by a key executive (Chief Medical Officer and Director) can signal confidence in the company's future prospects.
• The equity grants align management's financial interests with those of shareholders, promoting long-term value creation.

Future Outlook

The vesting schedule for the Restricted Stock Units extends over a four-year period, implying a continued service commitment from the reporting person to the issuer.

Industry Context

NA

Stakeholder Impact

• Shareholders: The grants increase insider ownership, potentially signaling management's commitment and aligning their interests with long-term shareholder value.
• Management (Timothy Pickett): Receives long-term equity incentives, tying personal wealth to company performance.

Next Steps

• Continued vesting of 37,593 Restricted Stock Units over a four-year period, subject to Timothy Pickett's continued service to Kindly MD, Inc.
• Future SEC filings (Forms 3, 4, 5, and Schedules 13D/G) on behalf of Timothy Pickett will be executed by the appointed attorneys-in-fact.

Key Dates

Keywords

Kindly MD, NAKA, Timothy Pickett, Insider Trading, Form 4, Restricted Stock Units, RSU, Restricted Stock Award, Equity Compensation, Chief Medical Officer, Director, SEC Filing, Beneficial Ownership